Skip to main content
Top
Published in: Obesity Surgery 6/2013

01-06-2013 | Clinical Research

Change in Levels of C-Reactive Protein (CRP) and Serum Cortisol in Morbidly Obese Patients After Laparoscopic Sleeve Gastrectomy

Authors: Jaime Ruiz-Tovar, Inmaculada Oller, Isabel Galindo, Carolina Llavero, Antonio Arroyo, Alicia Calero, María Diez, Lorea Zubiaga, Rafael Calpena

Published in: Obesity Surgery | Issue 6/2013

Login to get access

Abstract

Background

C-Reactive protein (CRP) has been associated with the macro- and microvascular effects of hypertension and diabetes mellitus. Referring to serum cortisol, it has been proposed to contribute to the pathogenesis of metabolic syndrome, and it has been demonstrated that weight loss normalizes cortisol levels and improves insulin resistance. The aims of this study were to analyze CRP and cortisol levels pre- and postoperatively in morbidly obese patients undergoing a laparoscopic sleeve gastrectomy and to correlate them with weight loss and parameters associated with cardiovascular risk.

Methods

A prospective study of all the morbidly obese patients undergoing laparoscopic sleeve gastrectomy as bariatric procedure between October 2007 and May 2011 was performed.

Results

A total of 40 patients were included in the study. CRP levels decreased significantly 12 months after surgery (median reduction of 8.9 mg/l; p = 0.001). Serum cortisol levels decreased significantly 6 months after surgery (median reduction of 34.9 μg/dl; p = 0.001). CRP values reached the normal range (<5 mg/l) 1 year after surgery. Referring to cortisol, a significant association was observed with the cardiovascular risk predictor (triglyceride/high-density lipoprotein cholesterol ratio) from the 6th month after surgery onward (Pearson correlation coefficient, 0.559; p = 0.008).

Conclusion

CRP levels are increased preoperatively and in the postoperative course up to 1 year after surgery. Serum cortisol levels remain elevated until the 6th month after surgery. From this moment onward, serum cortisol is associated with the cardiovascular risk predictor reflecting the cardiovascular risk decreasement during the weight loss.
Literature
2.
go back to reference Sullivan PW, Ghushchyan VH, Ben-Joseph R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res. 2008;17:1063–71.PubMedCrossRef Sullivan PW, Ghushchyan VH, Ben-Joseph R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res. 2008;17:1063–71.PubMedCrossRef
3.
go back to reference Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension, diabetes, dyslipidemia and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey 1999 to 2004. J Am Coll Surg. 2008;207:928–34.PubMedCrossRef Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension, diabetes, dyslipidemia and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey 1999 to 2004. J Am Coll Surg. 2008;207:928–34.PubMedCrossRef
4.
go back to reference Zhang F, Strain GW, Lei W, et al. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes Surg. 2011;21:305–9.PubMedCrossRef Zhang F, Strain GW, Lei W, et al. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes Surg. 2011;21:305–9.PubMedCrossRef
5.
go back to reference Marantos G, Daskalakis M, Karkavitsas N, et al. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopauseal females treated with restrictive bariatric surgery. World J Surg. 2011;35:2022–30.PubMedCrossRef Marantos G, Daskalakis M, Karkavitsas N, et al. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopauseal females treated with restrictive bariatric surgery. World J Surg. 2011;35:2022–30.PubMedCrossRef
6.
go back to reference Shah PS, Todkar JS, Shah SS. Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6:138–41.PubMedCrossRef Shah PS, Todkar JS, Shah SS. Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6:138–41.PubMedCrossRef
7.
go back to reference Gomez-Marcos MA, Recio-Rodriguez JI, Patino-Alonso MC, et al. Relationships between high-sensitive C-reactive protein and markers of arterial stiffness in hypertensive patients. Differences by sex. BMC Cardiovasc Disord. 2012;12:37.PubMedCrossRef Gomez-Marcos MA, Recio-Rodriguez JI, Patino-Alonso MC, et al. Relationships between high-sensitive C-reactive protein and markers of arterial stiffness in hypertensive patients. Differences by sex. BMC Cardiovasc Disord. 2012;12:37.PubMedCrossRef
8.
go back to reference Klempfner R, Leor J, Tenenbaum A, et al. Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis and inflammation in diabetic patients with coronary artery disease. Cardiovasc Diabetol. 2012;6:60.CrossRef Klempfner R, Leor J, Tenenbaum A, et al. Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis and inflammation in diabetic patients with coronary artery disease. Cardiovasc Diabetol. 2012;6:60.CrossRef
9.
go back to reference Varghese B, Swamy S, Srilakshmi MA, et al. Visceral adiposity in young patients with coronary artery disease—a case control study. Indian Heart J. 2012;64:284–9.PubMedCrossRef Varghese B, Swamy S, Srilakshmi MA, et al. Visceral adiposity in young patients with coronary artery disease—a case control study. Indian Heart J. 2012;64:284–9.PubMedCrossRef
10.
go back to reference Pasquali R, Vicennati V, Cacciari M, et al. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann NY Acad Sci. 2006;1083:111–28.PubMedCrossRef Pasquali R, Vicennati V, Cacciari M, et al. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann NY Acad Sci. 2006;1083:111–28.PubMedCrossRef
11.
12.
go back to reference Reinher T, Andler W. Cortisol and its relation to insulin resistance before and after weight loss in obese children. Horm Res. 2004;62:107–12.CrossRef Reinher T, Andler W. Cortisol and its relation to insulin resistance before and after weight loss in obese children. Horm Res. 2004;62:107–12.CrossRef
13.
go back to reference Gaziano JM, Hennekens CH, O’Donnell CJ, et al. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96:2520–5.PubMedCrossRef Gaziano JM, Hennekens CH, O’Donnell CJ, et al. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96:2520–5.PubMedCrossRef
14.
go back to reference Jiménez A, Casamitjana R, Flores L, et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg. 2012;256:1023–9.PubMedCrossRef Jiménez A, Casamitjana R, Flores L, et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg. 2012;256:1023–9.PubMedCrossRef
15.
go back to reference Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363–9.PubMedCrossRef Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363–9.PubMedCrossRef
16.
go back to reference Chen JY, Chou CH, Tsai WC, et al. Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with nonalcoholic fatty liver disease. J Am Soc Hypertens. 2012;6:253–60.PubMedCrossRef Chen JY, Chou CH, Tsai WC, et al. Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with nonalcoholic fatty liver disease. J Am Soc Hypertens. 2012;6:253–60.PubMedCrossRef
17.
go back to reference Aguilar Cordero MJ, González Jiménez E, Sánchez Perona J, et al. Obesidad y su relación con marcadores de inflamación y ácidos grasos de eritrocito en un grupo de adolescentes obesos. Nutr Hosp. 2012;27:161–4.PubMed Aguilar Cordero MJ, González Jiménez E, Sánchez Perona J, et al. Obesidad y su relación con marcadores de inflamación y ácidos grasos de eritrocito en un grupo de adolescentes obesos. Nutr Hosp. 2012;27:161–4.PubMed
18.
go back to reference Stenholm S, Maggio M, Lauretani F, et al. Anabolic and catabolic biomarkers as predictors of muscle strength decline: the InCHIANT study. Rejuvenation Res. 2010;13:3–11.PubMedCrossRef Stenholm S, Maggio M, Lauretani F, et al. Anabolic and catabolic biomarkers as predictors of muscle strength decline: the InCHIANT study. Rejuvenation Res. 2010;13:3–11.PubMedCrossRef
19.
go back to reference Schaap LA, Pluijm SM, Deeg DJ, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci. 2009;64:118–1189. Schaap LA, Pluijm SM, Deeg DJ, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci. 2009;64:118–1189.
21.
go back to reference Nelson D, Porta R, Blair K, et al. The duodenal switch for morbid obesity: modification of cardiovascular risk markers compared with standard bariatric surgeries. Am J Surg. 2012;203:603–8.PubMedCrossRef Nelson D, Porta R, Blair K, et al. The duodenal switch for morbid obesity: modification of cardiovascular risk markers compared with standard bariatric surgeries. Am J Surg. 2012;203:603–8.PubMedCrossRef
22.
go back to reference Anagnostis P, Athyros VG, Tzionalos K, et al. The pathogenetic role of cortisol in the metabolic síndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94:2692–701.PubMedCrossRef Anagnostis P, Athyros VG, Tzionalos K, et al. The pathogenetic role of cortisol in the metabolic síndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94:2692–701.PubMedCrossRef
23.
go back to reference Third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) final report 2002. Circulation. 2002;106:3143–421. Third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) final report 2002. Circulation. 2002;106:3143–421.
24.
go back to reference Heneghan HM, Meron-Eldar S, Brethauer SA, et al. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol. 2011;108:1499–507.PubMedCrossRef Heneghan HM, Meron-Eldar S, Brethauer SA, et al. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol. 2011;108:1499–507.PubMedCrossRef
Metadata
Title
Change in Levels of C-Reactive Protein (CRP) and Serum Cortisol in Morbidly Obese Patients After Laparoscopic Sleeve Gastrectomy
Authors
Jaime Ruiz-Tovar
Inmaculada Oller
Isabel Galindo
Carolina Llavero
Antonio Arroyo
Alicia Calero
María Diez
Lorea Zubiaga
Rafael Calpena
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 6/2013
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-013-0865-7

Other articles of this Issue 6/2013

Obesity Surgery 6/2013 Go to the issue